Validation of a Quality-of-Life Instrument for Patients With Nonmelanoma Skin Cancer

Abstract

These findings validate a new disease-specific quality-of-life instrument for patients with cervicofacial nonmelanoma skin cancer. Studies on the responsiveness of the Skin Cancer Index to clinical intervention are currently under way.